男性因素不育与糖尿病风险:一项基于登记资料的队列研究
这项前瞻性队列研究纳入1994年起在丹麦国家IVF登记库中因不育接受治疗的39516名男性,中位随访5.6年,发现男性因素不育可能预测日后糖尿病发生,且风险与不育问题严重程度相关;首个登记期(1994-2005)风险未显著升高,第二个登记期(2006-2012)风险升高。
要点
- 男性因素不育可能与日后糖尿病发生相关,风险与不育严重程度有关。
- 第二个IVF登记期(2006-2012)男性因素不育者糖尿病风险升高,HR=1.45(95%CI:1.06,1.97)。
- 少精、无精和精液缺乏者糖尿病风险分别升高,HR分别为1.44、2.10和3.20。
核心结论
- 研究提供证据表明男性因素不育可能预测日后糖尿病发生,且风险与潜在不育问题的严重程度相关。
- 这些发现支持男性生殖健康与躯体健康密切相关的既往研究,并强调进一步监测这些男性的重要性。
- 作者认为,在精液缺乏和无精男性中实施糖尿病筛查可能尤其相关。
研究设计与样本
- 前瞻性队列研究,从丹麦国家IVF登记库识别1994年起与女性伴侣接受不育治疗的39516名男性。
- 登记库包含夫妇不育假定原因(男性因素、女性因素、混合及不明原因不育)和不育治疗类型。
- 中位随访时间5.6年,从入组随访至2012年12月31日,使用国家糖尿病登记库(NDR)确定糖尿病发生。
- 排除在不育诊断前已有糖尿病史的男性。
- 采用以年龄为基本时间尺度的Cox比例风险模型估计风险比(HR)。
主要发现
- 随访期间共识别651例(1.6%)糖尿病病例。
- 与参照组相比,男性因素不育者糖尿病风险的调整HR在第一个IVF登记期为HR=1.08(95%CI:0.89,1.31),在第二个IVF登记期为HR=1.45(95%CI:1.06,1.97)。
- 评估男性因素不育各原因时,少精者调整HR=1.44(95%CI:1.01,2.06),无精者HR=2.10(95%CI:1.25,3.56),精液缺乏者HR=3.20(95%CI:1.00,10.31)。
- 纳入男性中,18499名(46.8%)有男性因素不育,21017名(53.2%)构成参照组。
关键数值与推荐
- 男性因素不育从第一个IVF登记库的变量「是」或「否」以及第二个IVF登记库的诊断代码(如少精症、无精症)识别。
- 参照组为男性因素不育为「否」的男性以及精液质量正常或已绝育的男性。
临床怎么用
- 作者认为,这些发现强调进一步监测这些男性的重要性。
- 作者认为,在精液缺乏和无精男性中实施糖尿病筛查可能尤其相关。
局限性
- 在第一个IVF登记库识别的男性中未发现风险升高,这可能与暴露错分有关,因为该时期无法获得男性因素不育的原因。
- 国家糖尿病登记库(NDR)不区分1型和2型糖尿病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is male factor infertility associated with an increased risk of developing diabetes? SUMMARY ANSWER: The study provides evidence that male factor infertility may predict later occurrence of diabetes mellitus with the risk being related to the severity of the underlying fertility problem. WHAT IS KNOWN ALREADY: Previous cross-sectional studies have shown an increased prevalence of comorbidities among infertile men when compared to controls. STUDY DESIGN, SIZE, DURATION: In this prospective cohort study, 39 516 men who had since 1994 undergone fertility treatment with their female partner were identified from the Danish national IVF register, which includes data on assumed cause of couple infertility (male/female factor, mixed and unexplained infertility) and type of fertility treatment. With a median follow-up time of 5.6 years, each man was followed for diabetes occurrence from enrollment until 31 December 2012 using the National Diabetes Register (NDR). Men with a history of diabetes prior to their fertility diagnosis were excluded. Hazard ratios (HR) were estimated by Cox proportional hazard models with age as the underlying time scale. In addition to analyzing the data for the entire IVF registration period (1994-2012), separate analyses were performed for men identified from the first (1994-2005) and second (2006-2012) IVF registration period owing to heterogeneity in the reporting of male factor infertility in these two time periods, because the reason for male factor infertility was not available from the first register. PARTICIPANTS/MATERIALS, SETTING, METHODS: Male factor infertility was identified from the variable 'yes' or 'no' from the first IVF register and through a diagnosis code (e.g. oligospermia, azoospermia) from the second IVF register. The reference group was men with male factor infertility (='no') and those with normal semen quality or sterilized men. Of the included men, 18 499 (46.8%) had male factor infertility and 21 017 (53.2%) made up the reference group. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 651 (1.6%) diabetes cases were identified during the follow-up period. The adjusted HR's for diabetes risk among men with male factor infertility when compared to the reference group were HR = 1.08 (95% CI: 0.89, 1.31) and HR = 1.45 (95% CI: 1.06, 1.97) for the first and second IVF registration period, respectively. When assessing the effects of individual causes of male factor infertility, the adjusted HR's for men with oligospermia, azoospermia and aspermia were HR = 1.44 (95% CI: 1.01, 2.06), HR = 2.10 (95% 1.25, 3.56) and HR = 3.20 (95% CI 1.00, 10.31), respectively. LIMITATIONS, REASONS FOR CAUTION: We found no increased risk among men identified from the first IVF register, which may be related to exposure misclassification as the reason for male factor infertility was not available from this time period. The NDR does not distinguish between type 1 and type 2 diabetes. WIDER IMPLICATIONS OF THE FINDINGS: These findings support previous studies that a man's reproductive and somatic health are closely intertwined and highlight the importance for further monitoring of these men. Further, implementation of diabetes screening may be especially relevant among aspermic and azoospermic men. STUDY FUNDING/COMPETING INTERESTS: This article is part of the ReproUnion collaborative study, co-financed by the European Union, Intereg V Öresund-Kattegat-Skagerrak. None of the authors declare any conflict of interest. TRIAL REGISTRATION NUMBER: None.
引用
- Glazer CH, Bonde JP, Giwercman A, et al. Risk of diabetes according to male factor infertility: a register-based cohort study. Hum Reprod. 2017. PMID: 28486688. doi:10.1093/humrep/dex097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。